Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pro Dex (PDEX) Accumulated Expenses (2016 - 2025)

Pro Dex's Accumulated Expenses history spans 12 years, with the latest figure at $4.3 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 18.65% year-over-year to $4.3 million; the TTM value through Dec 2025 reached $4.3 million, down 18.65%, while the annual FY2025 figure was $3.5 million, 885.55% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $4.3 million at Pro Dex, up from $4.1 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $5.2 million in Q4 2024 and bottomed at $353000.0 in Q2 2024.
  • The 5-year median for Accumulated Expenses is $2.7 million (2023), against an average of $2.6 million.
  • The largest annual shift saw Accumulated Expenses fell 21.41% in 2023 before it surged 885.55% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $1.8 million in 2021, then skyrocketed by 82.89% to $3.3 million in 2022, then decreased by 14.12% to $2.8 million in 2023, then soared by 83.91% to $5.2 million in 2024, then fell by 18.65% to $4.3 million in 2025.
  • Per Business Quant, the three most recent readings for PDEX's Accumulated Expenses are $4.3 million (Q4 2025), $4.1 million (Q3 2025), and $3.5 million (Q2 2025).